ArticleClinical, cosmetic and investigational dermatology2026
A Multicenter Cross-Sectional Study on Clinical Characteristics and Disease Burden of 1010 Patients with Moderate to Severe Atopic Dermatitis in Chinese Tertiary Hospitals.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the clinical characteristics of patients with moderate to severe atopic dermatitis (AD) visiting tertiary hospitals in China. Study Design: A multicenter cross-sectional survey was conducted on 1010 patients with moderate to severe AD. Their demographic characteristics, history of allergic diseases, inducing factors, treatment, disease assessment scales, and disease burden were analyzed. Place & Duration of the Study: The survey was conducted in 7 tertiary hospitals from October 2022 to October 2023, including Affiliated Hospital of Xuzhou Medical University, Yancheng First People's Hospital, Huai'an First People's Hospital, Lianyungang First People's Hospital, Lianyungang Second People's Hospital, Suqian Hospital of Nanjing Drum Tower Hospital Group and Xuzhou First People's Hospital. Results: Among the 1010 patients, the median age was 55.5 years, and 59.5% had severe AD. Female patients exhibited higher clinician-assessed SCORAD scores than male patients (P=0.016), although multivariate analysis identified age, personal allergic history, and smoking as independent risk factors for severity, with gender not retaining statistical significance. 50.7% had a personal history of allergic diseases, 26.9% had a family history, and allergic rhinitis was the most common. Season, skin moisturizing after bathing, smoking, and drinking were related to the disease. Treatment was mainly oral antihistamines and topical glucocorticoids. The SCORAD score was significantly positively correlated with the DLQI/CDLQI, POEM, NRS, and ADCT scores (P<0.01). Spearman correlation analysis demonstrated significant positive correlations between SCORAD and DLQI/CDLQI, POEM, NRS, and ADCT scores. The medical expenses of severe patients were higher than those of moderate patients (P<0.05). Conclusion: This study delineates the clinical profile and substantial burden of moderate-to-severe AD in Chinese tertiary hospitals, identifying older age, personal allergic history and smoking as independent risk factors for disease severity. These findings provide a basis for targeted management and informed clinical decision-making for this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.